Dysmenorrhea. Pelvic and perineal pain
Conditions
Interventions
Intervention 1: Intervention group: Prescription oral Menstrugloe capsule (500mg/day), produced by Gol Daroo Company for 2 months. Intervention 2: Intervention group: Prescription oral Vitamin E (200m
Treatment - Drugs
Intervention group: Prescription oral Menstrugloe capsule (500mg/day), produced by Gol Daroo Company for 2 months.
Intervention group: Prescription oral Vitamin E (200mg/day), produced by Daana Pharmacy Company for 2 months.
Control group: Prescription oral Placebo (1 capsule /day), produced by Gol Daroo Company for 2 months.
Sponsors
Vice Chancellor for Research and Technology, Hamadan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 30 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Student; Age between 18-30 years; Having Primary Dysmenorrhea; Lack of allergy to drugs, Exclusion criteria: Allergy to drugs; Unwillingness to continue cooperation.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of dysmenorrhea. Timepoint: Before the intervention and two month after the intervention. Method of measurement: Dysmenorrhea Multidimensional Speech Scale and McGill Pain ruler. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Shobeiri
Hamadan University of Medical Sciences
Outcome results
None listed